Table 2.

Estimated incidence of first psychiatric diagnoses during the first 14 to 90 days after a diagnosis of COVID-19 compared with other health events

		COVID-19	Influenza in matched cohort (n=26 497)		Other respiratory tract infection in matched cohort (n=44 775)		Skin infection in matched cohort (n=38 977)		Cholelithiasis in matched cohort (n=19 733)		Urolithiasis in matched cohort (n=28 827)		Fracture in matched cohort (n=37 841)
		% (95% CI)	% (95% CI)	p value	% (95% CI)	p value	% (95% CI)	p value	% (95% CI)	p value	% (95% CI)	p value	% (95% CI)	p value
Psychiatric illness		5·8 (5·2–6·4)	2·8 (2·5–3·1)	<0·0001	3·4 (3·1–3·7)	<0·0001	3·3 (3–3·7)	<0·0001	3·2 (2·8–3·7)	<0·0001	2·5 (2·2–2·8)	<0·0001	2·5 (2·2–2·7)	<0·0001
	Psychotic disorder	0·1 (0·08–0·2)	0·04 (0·01–0·10)	0·019	0·1 (0·06–0·16)	0·23	0·15 (0·096–0·24)	0·83	0·11 (0·054–0·24)	0·21	0·044 (0·016–0·12)	0·0051	0·16 (0·11–0·24)	0·77
	Mood disorder	2·0 (1·7–2·4)	1·1 (0·9–1·3)	<0·0001	1·5 (1·3–1·7)	0·0054	1·7 (1·5–1·9)	0·55	1·6 (1·3–1·9)	0·14	1·2 (1–1·4)	0·00011	1·4 (1·2–1·6)	0·0050
	Anxiety disorder	4·7 (4·2–5·3)	2·2 (1·9–2·5)	<0·0001	2·5 (2·2–2·8)	<0·0001	2·4 (2·1–2·7)	<0·0001	2·6 (2·2–3)	<0·0001	1·8 (1·6–2·1)	<0·0001	1·6 (1·4–1·8)	<0·0001
	Insomnia	1·9 (1·6–2·2)	0·6 (0·5–0·8)	<0·0001	0·8 (0·7–1·0)	<0·0001	0·89 (0·73–1·1)	<0·0001	1·1 (0·88–1·4)	<0·0001	0·57 (0·43–0·74)	<0·0001	0·7 (0·57–0·85)	<0·0001
Dementia in all participants		0·44 (0·33–0·60)	0·11 (0·06–0·20)	0·00044	0·25 (0·18–0·35)	0·00063	0·28 (0·20–0·39)	0·13	0·24 (0·14–0·38)	<0·0001	0·16 (0·09–0·28)	<0·0001	0·34 (0·25–0·44)	0·14
Dementia (among those ≥65 years)		1·6 (1·2–2·1)	0·66 (0·41–1·1)	0·0043	0·84 (0·61–1·1)	0·00071	0·70 (0·49–1·0)	0·00069	0·58 (0·36–0·94)	<0·0001	0·60 (0·38–0·95)	<0·0001	0·94 (0·68–1·3)	0·0036

p values obtained using a log-rank test. A breakdown of the results for different diagnoses of the anxiety disorders and mood disorders categories is provided in the appendix (pp 26–27).